Group B streptococcal bacteremia in a major teaching hospital in Malaysia: a case series of eighteen patients  by Eskandarian, N. et al.
International Journal of Infectious Diseases 17 (2013) e777–e780Case Report
Group B streptococcal bacteremia in a major teaching hospital in Malaysia: a case
series of eighteen patients
N. Eskandarian a, V. Neela a, Z. Ismail b, S.M. Puzi b, R.A. Hamat a, M.N.M. Desa c, S.A. Nordin a,*
aDepartment of Medical Microbiology and Parasitology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia
bDepartment of Medical Microbiology and Immunology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Cheras, Kuala Lumpur, Malaysia
cDepartment of Biomedical Sciences, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Selangor, Malaysia
A R T I C L E I N F O
Article history:
Received 10 November 2012
Received in revised form 6 January 2013
Accepted 12 January 2013
Corresponding Editor: Eskild Petersen,
Aarhus, Denmark
Keywords:
GBS
Bacteremia
Adult
Neonate
Malaysia
S U M M A R Y
Background: Group B Streptococcus (GBS) is a leading cause of infections such as meningitis and
septicemia in neonates and pregnant women; however the signiﬁcance of invasive GBS disease has not
been clearly deﬁned in non-pregnant adults.
Methods: We reviewed the hospital records of 18 cases with GBS bacteremia who attended the Universiti
Kebangsaan Malaysia Medical Centre from June 2010 to October 2011. We analyzed the clinical ﬁndings
of both bacteremic adults and neonates and compared them to previous studies of GBS bacteremia.
Serotyping was done by latex agglutination test using 10 distinct antisera (Ia, Ib, and II–IX).
Results: During the period of 1 year and 4 months, there were 18 patients with GBS bacteremia. Five cases
occurred in neonates, one in a parturient woman, and 12 in other adults. All neonates with bacteremia
were males and two of them were premature. Septicemia was the most common clinical presentation in
neonates. They were treated with intravenous (IV) penicillin G and gentamicin. The adults included nine
men (69%) and four women (31%). Their mean age was 60 years and all patients had more than two
underlying conditions. The most common clinical syndrome was pneumonia (n = 6, 46.5%). The others
were peritonitis (n = 3, 23.1%), primary bacteremia (n = 2, 15.5%), septic arthritis (n = 2, 15.5%), skin and
soft tissue infection (n = 1, 7.7%), meningitis (n = 1, 8%), urinary tract infection (n = 1, 8%), and
intravascular device infection (n = 1, 7.7%). Cardiovascular diseases (n = 7, 53.8%) were the most common
underlying conditions, and diabetes mellitus (n = 5, 38.5%) was second. The other co-morbid conditions
were hyperlipidemia (n = 3, 23.1%), renal disease (n = 3, 23.1%), liver disease and/or alcohol abuse (n = 3,
23.1%), autoimmune disease or immunosuppressive condition (n = 2, 15.5%), malignancy (n = 2, 15.5%),
respiratory disease (n = 1, 8%), and postpartum condition (n = 1, 8%), as well as miscellaneous conditions
including intravenous drug abuse, HIV infection, and trauma (n = 2, 15.5%). Polymicrobial bacteremia was
found in ﬁve (45.4%) cases and Staphylococcus aureus was the most common concurrent bacterial isolate.
Of the 18 GBS isolates in both adults and neonates, serotype Ia was predominant (38.9%), followed by VI
(27.8%), V (11.1%), and III (5.5%); the remaining 16.7% were non-typeable.
Conclusions: GBS bacteremia is a signiﬁcant problem and is associated with serious underlying disease,
which may result in a high rate of mortality, not only in neonates and pregnant women, but also in non-
pregnant adults.
 2013 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Group B Streptococcus (GBS), also known as Streptococcus
agalactiae, is a major cause of sepsis and meningitis in neonates, as
well as a wide variety of diseases in adulthood.1 In both pediatric
and adult populations, invasive GBS infection has been associated
with high mortality and morbidity.1 GBS neonatal infection is
divided into early-onset and late-onset disease. Early-onset* Corresponding author.
E-mail address: syaﬁnaz@medic.upm.edu.my (S.A. Nordin).
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http://dx.doi.org/10.1016/j.ijid.2013.01.011disease occurs within the ﬁrst week of life, while late-onset
disease occurs between 1 week and 3 months of age.2 The use of
intrapartum antibiotic prophylaxis in the prevention of prenatal
GBS infection has decreased the incidence of GBS disease by 70%
during the past decade.3 However, despite this, early-onset disease
remains a leading cause of neonatal infection and death in the
USA.3–5
GBS is also a signiﬁcant cause of invasive disease among the
elderly with underlying medical conditions.6 Over the past decade,
a dramatic increase in GBS infections has been seen in non-
pregnant adults, and more than two-thirds of GBS disease in the
USA now occurs in adults without postpartum condition.7ses. Published by Elsevier Ltd. All rights reserved.
Table 1
Demographic and clinical data of ﬁve neonates with group B streptococcal infection
Case No. Age at diagnosis Maturity Gender/race Clinical presentation Serotype Treatment Outcome
1 Day 0 34 weeks, 5 days Male/Chinese Septicemia, prematurity Ia PEN, GEN Died
2 Day 3 38 weeks, 2 days Male/Chinese Septicemia, nosocomial pneumonia,
respiratory distress, NNJ, GERD, TGA
Ia PEN, GEN Survived
3 Day 1 38 weeks, 8 days Male/Malay Septicemia, pneumonia, respiratory distress, NNJ NT PEN, GEN Survived
4 Day 0 36 weeks, 6 days Male/Malay Septicemia, prematurity, pneumonia,
respiratory distress, NNJ, PDA
VI PEN, GEN Survived
5 Day 7 39 weeks, 4 days Male/Malay Septicemia, hydrocele III PEN, GEN Survived
GEN, gentamicin; GERD, gastro-esophageal reﬂux disease; NNJ, neonatal jaundice; NT, non-typeable; PDA, patent ductus arteriosus; PEN, penicillin; TGA, transposition of
great arteries.
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Malaysia and data from Southeast Asia are limited. Therefore, the
aim of this study was to deﬁne the serotypes and review the
clinical information of patients with GBS bacteremia.
2. Methods
Universiti Kebangsaan Malaysia Medical Centre (UKMMC) is a
900-bed teaching hospital in Malaysia. GBS bacteremia was
diagnosed on the basis of isolation of GBS from blood culture.
We reviewed the demographic and clinical information of
neonates and adults who had GBS bacteremia between June
2010 and October 2011. Our study includes information on
demographic variables, associated underlying conditions, clinical
syndromes, treatment, and outcome. Bacteremia without a certain
infection source was classiﬁed as primary bacteremia, while
polymicrobial infections were deﬁned as the isolation of bacterial
species other than GBS from the same source. Pneumonia was
diagnosed on the basis of clinical signs of consolidation, chest X-
ray, and at least two of the following symptoms: fever, cough,
purulent sputum, and chest pain. Bacteremia was considered
community-acquired when the isolate was from a blood culture
collected in the outpatient department or within 72 h of admission.
All GBS were identiﬁed by internationally accepted and standard
microbiological techniques. Serotype identiﬁcation was carried outTable 2
Demographic and clinical data of 13 adults with group B streptococcal bacteremia
Case No. Age (years)/gender Race Clinical syndrome Underlying c
6 54/F Malay Peritonitis Hypertension
endometrial 
7 70/M Malay Meningitis Hyperlipidem
8 27/F Malay Primary bacteremia Postpartum 
9 36/M Malay Intravascular device
infection
HIV infection
10 65/F Malay CAP, peritonitis Nephritic syn
11 81/F Malay Septic arthritis GIST, bowel 
colon cancer
12 49/M Chinese UTI DM, hyperte
disease, neph
syndrome, g
13 65/M Chinese CAP, cellulitis DM, hyperte
hyperlipidem
14 87/M Chinese Pneumonia, peritonitis DM, hyperte
15 65/M Chinese CAP, septic arthritis DM, hyperte
16 65/M Chinese HAP Chemotherap
17 37/M Malay Primary bacteremia DM, hyperte
alcoholic, he
18 76/M Malay HAP Liver disease
pressure sore
AMC, amoxicillin–clavulanic acid; AMP, ampicillin; CAP, community-acquired pneumo
diabetes mellitus; DVT, deep vein thrombosis; F, Female; CEF, cefepime; GIST, gastroin
disease; IPM, imipenem; IVDU, intravenous drug user; LTBI, latent tuberculosis infection
non-typeable; SAM, ampicillin–sulbactam; TZP, piperacillin–tazobactam; UTI, urinary tusing the latex agglutination method with the Strep-B-Latex Kit
(Statens Serum Institut, Denmark).
3. Results
This was a descriptive study, involving the retrospective
analysis of patient records. Eighteen cases of GBS bacteremia in
patients attending UKMMC were identiﬁed during the study
period of 1 year and 4 months. Of these 18 patients, ﬁve were
neonates and 12 were non-pregnant adults; one case occurred in a
pregnant woman. Clinical features of all patients are summarized
in Tables 1 and 2.
In neonates with bacteremia, three were born at full term while
the other two were premature. Septicemia was the most common
manifestation of the disease. Three babies presented with
pneumonia, respiratory distress, and neonatal jaundice. Only
one baby presented with signs of digestive disorder and was
diagnosed to have gastro-esophageal reﬂux disease. Two babies
had congenital heart defects, which included transposition of the
great arteries and patent ductus arteriosus. Hydrocele was seen in
one case. The babies were treated with intravenous penicillin G
and gentamicin. All babies survived with the exception of one who
died on the day of admission (Table 1).
The adult patients comprised nine men (69%) and four women
(31%). Their mean age was 60 years, ranging from 27 to 87 years.ondition Polymicrobial
bacteremia
Serotype Treatment Outcome
, hyperlipidemia,
cancer
Negative Ia AMC Survived
ia, CUA, trauma Negative Ia ND Survived
Negative VI AMP Survived
, IVDU, LTBI, DVT Positive NT CLX, IPM Survived
drome Negative V SAM, CEF, VAN Survived
lymphoma, Positive V TZP, MTZ Survived
nsion, liver
ritic
lomerulonephritis
Negative NT SAM Survived
nsion,
ia, IHD, LVH
Positive Ia VAN Survived
nsion, IHD, stroke Positive VI IPM, AMC Died
nsion, gout Positive VI CLX Survived
y Negative VI CTX Died
nsion, liver disease,
art failure
Negative Ia ND Died
, alcoholic, Negative Ia ND Died
nia; CLX, cloxacillin; CTX, cotrimoxazole; CUA, calciﬁc uremic arteriopathy; DM,
testinal stromal tumor; HAP, hospital- acquired pneumonia; IHD, ischemic heart
; LVH, left ventricular hypertrophy; M, Male; MTZ, metronidazole; ND, no data; NT,
ract infection; VAN, vancomycin.
Table 3
Clinical syndromes of 13 adults with group B streptococcal bacteremia
Clinical syndrome No. (%) of patients
Pneumonia 6 (46.5)
Primary bacteremia 2 (15.5)
Peritonitis 3 (23.1)
Septic arthritis 2 (15.5)
Urinary tract infection 1 (7.7)
Skin and soft tissue infection 1 (7.7)
Meningitis 1 (7.7)
Intravascular device infection 1 (7.7)
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than two underlying conditions, as listed in Table 2. The clinical
syndromes are shown in Table 3 and were as follows: pneumonia
(n = 6, 46.5%), peritonitis (n = 3, 23.1%), arthritis (n = 2, 15.5%), skin
and soft tissue infection (n = 2, 15.5%), meningitis (n = 1, 7.7%),
urinary tract infection (n = 1, 7.7%), and intravascular device
infection (n = 1, 7.7%). There were only two cases (15.5%) of
primary bacteremia. The most common clinical syndrome was
pneumonia. All six patients with pneumonia were elderly, aged 
65 years, and three of them had diabetes mellitus as well as
hypertension. Of the six cases of pneumonia, three were
community-acquired and three were hospital-acquired.
The underlying medical conditions of the 13 adults with GBS
bacteremia are presented in Table 4. In the current series,
cardiovascular diseases (n = 7, 53.8%) were the most common
underlying condition among adults, whereas respiratory disease
was the least (n = 1, 7.7%). Diabetes mellitus, which was present in
ﬁve cases (38.5%), was the second most prominent underlying
condition and associated with hypertension in all ﬁve patients. The
other co-morbid conditions were hyperlipidemia (n = 3, 23.1%),
renal disease (n = 3, 23.1%), liver disease and/or alcohol abuse
(n = 3, 23.1%), autoimmune disease or immunosuppressive condi-
tion (n = 2, 15.5%), and malignancy (n = 2, 15.5%). One patient was
in the postpartum period. Other underlying conditions included
intravenous drug abuse, HIV infection, and trauma. In cases of
polymicrobial bacteremia, the concordant isolates included
Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli,
coagulase-negative staphylococci, and Gram-negative cocci (un-
speciﬁed). All of the patients received antibiotic therapy and all
except four survived. No data are available for treatment of two
adults who died (Table 2).Table 4
Underlying medical conditions of 13 adults with group B streptococcal bacteremia
Condition No. (%) of patients
with condition
Cardiovascular diseasea 7 (53.8)
Diabetes mellitus 5 (38.5)
Hyperlipidemia 3 (23.1)
Liver disease and/or alcohol abuse 3 (23.1)
Renal diseaseb 3 (23.1)
Autoimmune disease or immunosuppressive conditionc 2 (15.5)
Malignancyd 2 (15.5)
Postpartum 1 (7.7)
Respiratory diseasee 1 (7.7)
Miscellaneousf 2 (15.5)
a Includes hypertension, deep venous thrombosis, ischemic heart disease, left
ventricular hypertrophy, and stroke.
b Includes calciﬁc uremic arteriopathy, nephritic syndrome, and glomerulone-
phritis.
c Includes chemotherapy and gout.
d Includes endometrial cancer, gastrointestinal stromal tumor, bowel lymphoma,
and colon cancer.
e Includes latent tuberculosis infection.
f Includes intravenous drug user, HIV infection, and trauma.The serotypes of the GBS strains are presented in Tables 1 and 2.
Serotype Ia was the most prevalent capsular polysaccharide type,
accounting for 38.9% of cases, followed by serotypes VI (27.8%), V
(11.1%), III (5.5%), and non-typeable (16.7%). Serotypes II, IV, and
VII –IX were not found.
4. Discussion
GBS is a Gram-positive coccus associated mainly with infection
in newborns.4 Antibiotic prophylaxis during the intrapartum
period for GBS carrier patients has reduced the rate of neonatal GBS
infection.5 However, GBS can cause infection in pregnant and non-
pregnant adults.4 A recent study from a teaching hospital in
Malaysia reported the vaginal carriage rate of GBS in pregnant
women to be 9.7% and the annual incidence of GBS septicemia in
babies to be 0.4/1000 live-births.8
In the present study, we reported 18 cases of GBS bacteremia
occurring in ﬁve neonates and 13 adults. Although the current
investigation involved a small number of GBS bacteremia in
neonates, the data were compared with prior data for potential
similar patterns. All ﬁve cases were male, which supports the
ﬁndings of other studies on gender distribution.9,10 The reason for
male dominance is unclear, but perhaps it is related to sex-linked
factors in host susceptibility.9
In Malaysia it is not standard policy to screen each pregnant
woman for GBS carriage during antenatal checks. Therefore, if they
are GBS carriers, they can transfer this to their newborn, which
explains our neonate cases who presented within the ﬁrst 7 days of
life.
In our series, GBS bacteremia occurred in adults with varied
underlying diseases, including diabetes mellitus, cardiovascular
failure, renal disorders, liver disease, skin and soft tissue infection,
and malignancy, as well as autoimmune diseases or immunosup-
pressive conditions. Cardiovascular diseases were observed to be
the most frequently associated underlying medical condition in
this study. However, since our study is not population-based and
our estimate is based on a single institution with a small sample
size, the explanation of the results may include some regional or
institutional bias. Thus, a larger study should be performed to
determine whether cardiovascular disease is the most common
underlying medical condition or not in this local geographical
region.
In other studies, diabetes mellitus was the most prevalent risk
factor in populations from Europe, the USA,4,11–14 and Southeast
Asian countries including Malaysia.1,15 Malignancy was less
predominant, which is parallel to previous ﬁndings in Malaysia15
and France,13 but is different from Western countries,4,11 as well as
Taiwan.7
In this study, the most frequent clinical syndrome was
pneumonia, which is different from prior studies in Malaysia,
Taiwan, and Western countries; these have shown the skin and soft
tissues to be the most common sites of infection.7,11,15,16 Only one
patient had a skin and soft tissue infection, which was cellulitis.
Polymicrobial bacteremia was found in ﬁve (45.4%) cases and S.
aureus was the most common concurrent bacterial isolate in GBS
bacteremic patients, similar to previous reports.11,12,15
In the USA and Europe, serotypes Ia, II, III, and V predominate,
and in Japan, serotypes Ib and III were determined to be the most
common GBS strains among neonatal and adult cases.1,6,14,17
Serotypes III and Ia have become increasingly frequent among
pregnant women in Korea.5 In Malaysia, a recent study from a
teaching hospital revealed that serotypes Ia and VI were
predominant among pregnant women, similar to the ﬁndings of
our investigation in neonates and adults.15 Interestingly, these two
common serotypes are related to mortality. Of ﬁve patients who
died, three demonstrated serotype Ia and two demonstrated
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virulent in humans.
In the present study, the overall mortality rate was 5/18 (28%),
which comprised 1/5 infant cases (20%) and 4/13 adult cases (31%).
We found that the case fatality rate in adults was slightly higher
than those of previous reports, which have ranged from 9.5% to
20.2%.1,7,11,12,16 Mortality among patients aged 67 years was 75%
(3/4), three times that of those younger than 67 years (25%, 1/4);
this is concordant with previous ﬁndings in the USA and
Taiwan.7,12
Of the four adult patients who died, only one had polymicrobial
bacteremia and the other three had GBS bacteremia alone. Thus, in
support of previous ﬁndings in Japan,1 there was no signiﬁcant
association between polymicrobial infection and fatality. Mortality
seems to be highly dependent on the presence of pneumonia, and
the reported mortality from pneumonia with GBS bacteremia has
been considered high.12
In conclusion, GBS infection in non-pregnant adults is increas-
ing and usually affects the elderly and those with underlying
medical conditions, particularly cardiovascular diseases and
diabetes mellitus. Preventive strategies, such as a GBS vaccine
are likely to be important in both infant and adult groups.
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